Merck Group Says On Track To Hit EUR 25 Bln Sales Target By 2025

Merck KGaA (MKGAY.PK), a German science and technology firm, said on Thursday that it is on track to reach its mid-term growth target of 25 billion euros in sales by 2025.

To meet the sales target, Merck said it will continue to focus on its Big 3 businesses, including Process Solutions and Life Science Services, new Healthcare products, and Semiconductor Solutions.

By 2025, Big 3 is projected to generate around 80 percent of targeted sales growth, and over 50 percent of total sales in 2025.

Until 2025, the Group expects a growth in sales organically by at least 6 percent on average per year, equating to an increase of over 1 billion euros annually.

To achieve its objectives, the company is making targeted investments worldwide to expand its regional capacities. In addition to its organic growth objectives, Merck plans further in-licensing and bolt-on acquisitions.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ride-hailing and delivery platform Uber Technologies, Inc. reported Wednesday weak profit in its fourth quarter, while adjusted EBITDA surged from last year with strong revenue growth above market view. Gross bookings increased and the company projects higher gross bookings in the first quarter. Nelson Chai, CFO, said the company significantly exceeded profitability outlook in 2022, ... Societe Generale Group reported Wednesday a weak profit in its fourth quarter, despite higher net banking income. Further, the French Financial services major proposed a dividend and around 440 million euros share buyback program. The company also confirmed fiscal 2025 financial targets. City of Industry, California-based Titans Global Inc. is recalling certain JSJ branded cakes citing potential to contain undeclared eggs, a known allergen, the U.S. Food and Drug Administration said. The recall involves its 95g packages of JSJ Chocolate Cake, JSJ ZSR Cake, and JSJ DMC Leaf Cake food treats.
Follow RTT